期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | Urolithiasis LetPub Score 5.1
50 ratings
Rate
Reputation 6.3 Influence 3.9 Speed 7.0 | ||||||||||||||||
期刊簡稱 | UROLITHIASIS | ||||||||||||||||
ISSN | 2194-7228 | ||||||||||||||||
E-ISSN | 2194-7236 | ||||||||||||||||
h-index | 55 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 10.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/240 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ures | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||
主題領域 | UROLOGY & NEPHROLOGY | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 年6回刊行 | ||||||||||||||||
創刊年 | 1973 | ||||||||||||||||
每年文章數 | 98每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 22.49% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2194-7228%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Urolithiasis] 的評論 | 撰寫評論 |
作者: bosy 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-11-29 17:14:22 評論於 The editors are very responsible, work at a fast pace, and most importantly, academic editors (including the chief editor) have the valuable ability to make decisions on manuscript acceptance based on their own professional judgment, rather than relying solely on the opinions of reviewers, some of whom may be objective and some of whom may be perfunctory. For perfunctory review comments, the editors simply ignore them, which is greatly commendable! ![]() ![]() |
作者: 坠星红毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-13 16:09:18 評論於 Hello senior, I would like to ask if after submitting in the system, do I need to resubmit in the link in the email? I received an email saying the submission was incomplete, and the link in it led me to resubmit ![]() ![]() |
作者: 震雷舒婕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-19 13:23:52 評論於 So what is the result? ![]() ![]() |
作者: 震雷舒婕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-11 13:01:51 評論於 It's been almost two months since it was sent back for repairs, but there's still no news ![]() ![]() |
作者: 震雷舒婕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-21 23:30:38 評論於 I have been here for a month ![]() ![]() |
作者: 是你的乐琴呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-26 16:02:21 評論於 After receiving the revisions, it took almost a week to make the necessary changes and send them back ![]() ![]() |
作者: 是你的乐琴呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-24 08:40:53 評論於 On 12.29 became 1 reviewer received, and then no change ![]() ![]() |
作者: 奉天可馨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-16 22:21:38 評論於 How is this article, have you received it? ![]() ![]() |
作者: 是你的乐琴呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-14 22:00:53 評論於 Editor has been appointed for 18 days and there is still no change. Does anyone know what's going on ![]() ![]() |
作者: 苍风凝梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-18 12:05:01 評論於 Thank you so much! ![]() ![]() |
作者: 岱宗田然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-17 14:13:56 評論於 You can send an email to sandra.lesny@springer.com to urge them. This person is more responsive. The other email on the official website is unlikely to reply, or the replies are just generic responses ![]() ![]() |
作者: 岱宗田然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-17 12:55:12 評論於 I waited for two months without finding a reviewer, so I withdrew the submission... I used to think this journal was pretty fast, with results in about a month, but now I can't find any reviewers ![]() ![]() |
作者: 苍风凝梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-15 19:16:08 評論於 Review speed: 6.0 | Submission success rate: 25.0 Experience sharing: I submitted my paper on September 16th, and it was displayed in the invitation of experts on October 1st. It is now November 15th, but there has been no changes on the page and I have not received any emails or messages. I am really anxious as I am about to graduate. Can anyone please tell me what is going on and what should I do? ![]() ![]() |
作者: 苍风凝梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-15 17:56:10 評論於 I also want to ask, it has been two months since submitting the paper, and still 5 reviewers invited, I don't know what the situation is ![]() ![]() |
作者: 苍风凝梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-15 12:17:41 評論於 How is the situation going? Please let me know ![]() ![]() |
作者: 岱宗田然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-15 16:40:59 評論於 I have submitted my paper through Springer's new system a month ago, and I have received invitations from 4 reviewers. Will it show as "under review" status? ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:43:35 評論於 The method of relative quantification in qPCR is the ΔΔCT method, which first calibrates with reference genes, and then calculates the difference between samples and control groups ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:13:31 評論於 Calculate the average value (Mean) using Average(), the standard deviation (SD) using STDEV.S(), and the standard error (SEM) using STDEV.S()/COUNT()^0.5 ![]() ![]() |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 11:26:56 評論於 How to calculate the margin of error? ![]() ![]() |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 08:44:22 評論於 How to handle the results of qPCR? ![]() ![]() |
作者: 多罗涵博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-29 21:38:38 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Main research direction: experience sharing of urinary stones Comments: The first submission was rejected, it took 1 week, and a lot of feedback was provided. After revising based on the feedback, it was accepted. The whole process took about 2 months. The editor was very responsible. Thumbs up ![]() ![]() |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 18:20:31 評論於 Awesome ![]() ![]() |
作者: 云来之南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-26 17:45:45 評論於 IF1.816 Hardy-Tau 2018-03-26 published:: Acceptance rate: about 50% Review time: about 1 month for first review, one month for major revisions. However, not many major revisions needed. Total of two reviewers. Made revisions based on reviewers' comments. Accepted in mid-March. Article is published by Springer. No publication fee required. Now available online ![]() ![]() |
作者: 云来之南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-26 17:30:47 評論於 Review Speed: 1.0 | Acceptance Rate: 50.0 Experience Sharing: One month notice for major revisions after the first review. However, there are not many comments. There are a total of two reviewers. Make revisions based on the comments of the reviewers. Accepted in mid-March. The article is published by Springer. No page charges. The article is now online ![]() ![]() |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 14:14:44 評論於 From below 1.5 points, it is now approaching 2 points, which is a good sign. This magazine is worth having ![]() ![]() |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us